Ginkgo Bioworks slumps 14% after projecting FY26 cash burn of $125M-$150M
Ginkgo Bioworks Holdings, Inc. · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $9.14
-18% in 7d after detection
Post-detection moves
1h
—
1d
-2.9%
3d
-3.8%
7d
-18%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS